These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6942421)

  • 1. Electrophoretically detected germinal mutations induced in the mouse by ethylnitrosourea.
    Johnson FM; Lewis SE
    Proc Natl Acad Sci U S A; 1981 May; 78(5):3138-41. PubMed ID: 6942421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ENU mutagenesis in the mouse electrophoretic specific-locus test, 1. Dose-response relationship of electrophoretically-detected mutations arising from mouse spermatogonia treated with ethylnitrosourea.
    Lewis SE; Barnett LB; Sadler BM; Shelby MD
    Mutat Res; 1991 Aug; 249(2):311-5. PubMed ID: 2072974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of two-dimensional electrophoresis to detect mutations induced in mouse spermatogonia by ethylnitrosourea.
    Marshall RR; Raj AS; Grant FJ; Heddle JA
    Can J Genet Cytol; 1983 Oct; 25(5):457-66. PubMed ID: 6652565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose--response curve for ethylnitrosourea-induced specific-locus mutations in mouse spermatogonia.
    Russell WL; Hunsicker PR; Raymer GD; Steele MH; Stelzner KF; Thompson HM
    Proc Natl Acad Sci U S A; 1982 Jun; 79(11):3589-91. PubMed ID: 6954505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The induction of forward and reverse specific-locus mutations and dominant cataract mutations in spermatogonia of treated strain DBA/2 mice by ethylnitrosourea.
    Favor J; Neuhäuser-Klaus A; Ehling UH
    Mutat Res; 1991 Aug; 249(2):293-300. PubMed ID: 2072972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The frequency of dominant cataract and recessive specific-locus mutations in mice derived from 80 or 160 mg ethylnitrosourea per kg body weight treated spermatogonia.
    Favor J
    Mutat Res; 1986 Aug; 162(1):69-80. PubMed ID: 3724777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dose fractionation on the ethylnitrosourea induction of specific-locus mutations in mouse spermatogonia.
    Russell WL; Hunsicker PR; Carpenter DA; Cornett CV; Guinn GM
    Proc Natl Acad Sci U S A; 1982 Jun; 79(11):3592-3. PubMed ID: 6954506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse spermatogonia exposed to a high, multiply fractionated dose of a cancer chemotherapeutic drug: mutation analysis by electrophoresis.
    Johnson FM; Lewis SE
    Mutat Res; 1981 Apr; 81(2):197-202. PubMed ID: 7242541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The frequency of dominant cataract and recessive specific-locus mutations and mutation mosaics in F1 mice derived from post-spermatogonial treatment with ethylnitrosourea.
    Favor J; Neuhäuser-Klaus A; Ehling UH
    Mutat Res; 1990 Apr; 229(2):105-14. PubMed ID: 2320023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linear dose-response relationship of erythrocyte enzyme-activity mutations in offspring of ethylnitrosourea-treated mice.
    Charles DJ; Pretsch W
    Mutat Res; 1987 Jan; 176(1):81-91. PubMed ID: 3796661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethylnitrosourea mutagenesis and the isolation of mutant alleles for specific genes located in the T region of mouse chromosome 17.
    Bode VC
    Genetics; 1984 Oct; 108(2):457-70. PubMed ID: 6500258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific-locus test shows ethylnitrosourea to be the most potent mutagen in the mouse.
    Russell WL; Kelly EM; Hunsicker PR; Bangham JW; Maddux SC; Phipps EL
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5818-9. PubMed ID: 293686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of a mouse alpha-globin gene mutation induced by ethylnitrosourea.
    Popp RA; Bailiff EG; Skow LC; Johnson FM; Lewis SE
    Genetics; 1983 Sep; 105(1):157-67. PubMed ID: 6618166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation-induced forward and reverse specific locus mutations and dominant cataract mutations in treated strain BALB/c and DBA/2 male mice.
    Favor J; Neuhäuser-Klaus A; Ehling UH
    Mutat Res; 1987 Mar; 177(1):161-9. PubMed ID: 3821762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmission of mutations in the lacI transgene to the offspring of ENU-treated Big Blue male mice.
    Barnett LB; Tyl RW; Shane BS; Shelby MD; Lewis SE
    Environ Mol Mutagen; 2002; 40(4):251-7. PubMed ID: 12489115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-repetition increases the mutagenic effectiveness of N-ethyl-N-nitrosourea in mouse spermatogonia.
    Hitotsumachi S; Carpenter DA; Russell WL
    Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6619-21. PubMed ID: 3863118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ENU mutagenesis in the mouse electrophoretic specific-locus test. 2. Mutational studies of mature oocytes.
    Lewis SE; Barnett LB; Shelby MD
    Mutat Res; 1992 Dec; 296(1-2):129-33. PubMed ID: 1279399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic analysis of an N-ethyl-N-nitrosourea-induced mutation at the hemoglobin beta-chain locus in mice.
    Murota T; Shibuya T; Tutikawa K
    Mutat Res; 1982; 104(4-5):317-21. PubMed ID: 7110170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the dominant cataract and recessive specific-locus mutation rates induced by treatment of male mice with ethylnitrosourea.
    Favor J
    Mutat Res; 1983 Aug; 110(2):367-82. PubMed ID: 6877261
    [No Abstract]   [Full Text] [Related]  

  • 20. Dominant lethal mutations induced in mouse spermatogonia by antineoplastic drugs.
    Goldstein LS
    Mutat Res; 1984 Aug; 140(4):193-7. PubMed ID: 6472329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.